Research & products
We run to, not from, the world’s biggest health challenges.
The journey to invention and discovery is guided by science – and inspired by patients
Our purpose is to save and improve lives for generations. Our strategy is simple: We follow the science. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.
Our work in numbers
people employed in research and development
people reached through our major programs and partnerships
invested in R&D in 2020
We address the world’s most difficult health challenges, following world-class science
Discovery & development
Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. We are grateful to the thousands of volunteers who participate in our clinical trials – making this all possible.
Our commitment to patients is unwavering
As long as there are still patients in hospitals, doctors and nurses desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.
Invention begins here
Our scientists are applying the latest groundbreaking research technologies and revolutionizing how we discover and develop medicines and vaccinesView our stories
New podcast: On the hunt for the next big innovation
Through business development and licensing, Merck Research Laboratories stays primed for new opportunities for our pipeline through partnershipsRead more
Our commitment to HIV treatments and prevention through the years
We continue to work at the forefront of the fight against HIVRead more
Why we’re excited to partner on Johnson & Johnson’s COVID-19 vaccine
Our company has teamed with Johnson & Johnson to ramp up vaccine production - here’s what it meansRead more
Our fourth-quarter and full-year 2020 financial results
Merck announced fourth-quarter worldwide sales of $12.5 billion – an increase of 5%, and full-year 2020 worldwide sales of $48.0 billion – an increase of 2%. Excluding the impact from foreign exchange, sales grew 4%. The company anticipates full-year 2021 worldwide sales to be between $51.8 billion and $53.8 billion, including a positive impact from […]See earnings
No matter rain, nor snow…
In the face of increasing global demand for one of our cancer medicines, our manufacturing teams in Durham, North Carolina, have gone above and beyond. When the other suppliers stopped production, Merck responded by stretching the production processes and enabling production to the full extent of our manufacturing equipment capacity. The Durham team increased production […]Read more